Catalyst Wire Dossier Catalyst Wire Dossier

Hema-NeoTIL01 Cell Infusion Therapy

Hema-NeoTIL01 · The First Affiliated Hospital of Soochow University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hema-NeoTIL01 Cell Infusion Therapy, covering 2024-08-19 to 2024-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia [EARLY_Phase 1]

See pricing